You are here:
NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma
Technology appraisal guidance
Reference number:
TA306
Published:
26 February 2014
Guidance
Tools and resources
Information for the public
Evidence
History
Download guidance (PDF)
Overview
1 Guidance
2 The technology
3 The manufacturer's submission
4 Consideration of the evidence
5 Implementation
6 Related NICE guidance
7 Review of guidance
8 Appraisal Committee members and NICE project team
9 Sources of evidence considered by the Committee
Changes after publication
About this guidance
Changes after publication
April 2014
: Wording changes in sections 4.8 and 4.9.
Next page
About this guidance
Previous page
9 Sources of evidence considered by the Committee